Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes-Reference-Cited by-同舟云学术

Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes

Published:2020-11 Issue:5 Volume:61 Page:
ISSN:0021-9509
Container-title:The Journal of Cardiovascular Surgery
language:
Short-container-title:J Cardiovasc Surg

Author:

Rocha-Gomes João N.,Saraiva Francisca A.,Cerqueira Rui J.,Moreira Raquel,Ferreira Ana F.,Barros António S.,Amorim Mário J.,Pinho Paulo,Lourenço André P.,Leite-Moreira Adelino F.

Publisher

Edizioni Minerva Medica

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Surgery

Link

https://www.minervamedica.it/pdf.php?cod=R37Y2020N05A0662

Reference50 articles.

1. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes

2. 2018 ESC/EACTS Guidelines on myocardial revascularization

3. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

4. Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

5. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redo CABG: Where Every Ounce of Experience Matters Regardless of the Technique;Heart, Lung and Circulation;2021-09

2. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting;European Heart Journal - Cardiovascular Pharmacotherapy;2020-07-06